181 related articles for article (PubMed ID: 28960140)
21. Intrinsic toxicity of the cellular prion protein is regulated by its conserved central region.
Roseman GP; Wu B; Wadolkowski MA; Harris DA; Millhauser GL
FASEB J; 2020 Jun; 34(6):8734-8748. PubMed ID: 32385908
[TBL] [Abstract][Full Text] [Related]
22. Increased proportions of C1 truncated prion protein protect against cellular M1000 prion infection.
Lewis V; Hill AF; Haigh CL; Klug GM; Masters CL; Lawson VA; Collins SJ
J Neuropathol Exp Neurol; 2009 Oct; 68(10):1125-35. PubMed ID: 19918124
[TBL] [Abstract][Full Text] [Related]
23. Structural insights into the interaction between prion protein and nucleic acid.
Lima LM; Cordeiro Y; Tinoco LW; Marques AF; Oliveira CL; Sampath S; Kodali R; Choi G; Foguel D; Torriani I; Caughey B; Silva JL
Biochemistry; 2006 Aug; 45(30):9180-7. PubMed ID: 16866364
[TBL] [Abstract][Full Text] [Related]
24. A conformational switch controlling the toxicity of the prion protein.
Frontzek K; Bardelli M; Senatore A; Henzi A; Reimann RR; Bedir S; Marino M; Hussain R; Jurt S; Meisl G; Pedotti M; Mazzola F; Siligardi G; Zerbe O; Losa M; Knowles T; Lakkaraju A; Zhu C; Schwarz P; Hornemann S; Holt MG; Simonelli L; Varani L; Aguzzi A
Nat Struct Mol Biol; 2022 Aug; 29(8):831-840. PubMed ID: 35948768
[TBL] [Abstract][Full Text] [Related]
25. Expression of the Prion Protein Family Member Shadoo Causes Drug Hypersensitivity That Is Diminished by the Coexpression of the Wild Type Prion Protein.
Nyeste A; Bencsura P; Vida I; Hegyi Z; Homolya L; Fodor E; Welker E
J Biol Chem; 2016 Feb; 291(9):4473-86. PubMed ID: 26721882
[TBL] [Abstract][Full Text] [Related]
26. Neurotoxic mutants of the prion protein induce spontaneous ionic currents in cultured cells.
Solomon IH; Huettner JE; Harris DA
J Biol Chem; 2010 Aug; 285(34):26719-26. PubMed ID: 20573963
[TBL] [Abstract][Full Text] [Related]
27. Sialylation of the prion protein glycans controls prion replication rate and glycoform ratio.
Katorcha E; Makarava N; Savtchenko R; Baskakov IV
Sci Rep; 2015 Nov; 5():16912. PubMed ID: 26576925
[TBL] [Abstract][Full Text] [Related]
28. A cationic tetrapyrrole inhibits toxic activities of the cellular prion protein.
Massignan T; Cimini S; Stincardini C; Cerovic M; Vanni I; Elezgarai SR; Moreno J; Stravalaci M; Negro A; Sangiovanni V; Restelli E; Riccardi G; Gobbi M; Castilla J; Borsello T; Nonno R; Biasini E
Sci Rep; 2016 Mar; 6():23180. PubMed ID: 26976106
[TBL] [Abstract][Full Text] [Related]
29. Prion infection of mouse neurospheres.
Giri RK; Young R; Pitstick R; DeArmond SJ; Prusiner SB; Carlson GA
Proc Natl Acad Sci U S A; 2006 Mar; 103(10):3875-80. PubMed ID: 16495413
[TBL] [Abstract][Full Text] [Related]
30. Octapeptide repeat region of prion protein (PrP) is required at an early stage for production of abnormal prion protein in PrP-deficient neuronal cell line.
Sakudo A; Wu G; Onodera T; Ikuta K
Biochem Biophys Res Commun; 2008 Jan; 365(1):164-9. PubMed ID: 17981146
[TBL] [Abstract][Full Text] [Related]
31. Copper- and Zinc-Promoted Interdomain Structure in the Prion Protein: A Mechanism for Autoinhibition of the Neurotoxic N-Terminus.
Evans EGB; Millhauser GL
Prog Mol Biol Transl Sci; 2017; 150():35-56. PubMed ID: 28838668
[TBL] [Abstract][Full Text] [Related]
32. Electron paramagnetic resonance evidence for binding of Cu(2+) to the C-terminal domain of the murine prion protein.
Cereghetti GM; Schweiger A; Glockshuber R; Van Doorslaer S
Biophys J; 2001 Jul; 81(1):516-25. PubMed ID: 11423433
[TBL] [Abstract][Full Text] [Related]
33. Altered Domain Structure of the Prion Protein Caused by Cu
McDonald AJ; Leon DR; Markham KA; Wu B; Heckendorf CF; Schilling K; Showalter HD; Andrews PC; McComb ME; Pushie MJ; Costello CE; Millhauser GL; Harris DA
Structure; 2019 Jun; 27(6):907-922.e5. PubMed ID: 30956132
[TBL] [Abstract][Full Text] [Related]
34. Melanin or a Melanin-Like Substance Interacts with the N-Terminal Portion of Prion Protein and Inhibits Abnormal Prion Protein Formation in Prion-Infected Cells.
Hamanaka T; Nishizawa K; Sakasegawa Y; Oguma A; Teruya K; Kurahashi H; Hara H; Sakaguchi S; Doh-Ura K
J Virol; 2017 Mar; 91(6):. PubMed ID: 28077650
[TBL] [Abstract][Full Text] [Related]
35. An N-terminal polybasic domain and cell surface localization are required for mutant prion protein toxicity.
Solomon IH; Khatri N; Biasini E; Massignan T; Huettner JE; Harris DA
J Biol Chem; 2011 Apr; 286(16):14724-36. PubMed ID: 21385869
[TBL] [Abstract][Full Text] [Related]
36. Assessment of the PrPc Amino-Terminal Domain in Prion Species Barriers.
Davenport KA; Henderson DM; Mathiason CK; Hoover EA
J Virol; 2016 Dec; 90(23):10752-10761. PubMed ID: 27654299
[TBL] [Abstract][Full Text] [Related]
37. Utility of RNAi-mediated prnp gene silencing in neuroblastoma cells permanently infected by prions: potentials and limitations.
Kim Y; Han B; Titlow W; Mays CE; Kwon M; Ryou C
Antiviral Res; 2009 Nov; 84(2):185-93. PubMed ID: 19748523
[TBL] [Abstract][Full Text] [Related]
38. Both N-Terminal and C-Terminal Histidine Residues of the Prion Protein Are Essential for Copper Coordination and Neuroprotective Self-Regulation.
Schilling KM; Tao L; Wu B; Kiblen JTM; Ubilla-Rodriguez NC; Pushie MJ; Britt RD; Roseman GP; Harris DA; Millhauser GL
J Mol Biol; 2020 Jul; 432(16):4408-4425. PubMed ID: 32473880
[TBL] [Abstract][Full Text] [Related]
39. Lentivector-mediated RNAi efficiently suppresses prion protein and prolongs survival of scrapie-infected mice.
Pfeifer A; Eigenbrod S; Al-Khadra S; Hofmann A; Mitteregger G; Moser M; Bertsch U; Kretzschmar H
J Clin Invest; 2006 Dec; 116(12):3204-10. PubMed ID: 17143329
[TBL] [Abstract][Full Text] [Related]
40. Synthetic prions and other human neurodegenerative proteinopathies.
Le NT; Narkiewicz J; Aulić S; Salzano G; Tran HT; Scaini D; Moda F; Giachin G; Legname G
Virus Res; 2015 Sep; 207():25-37. PubMed ID: 25449570
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
